- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MBI spurs review of Nycomed patent
The U.S. Patent Office has granted a petition from Molecular Biosystems of San Diego asking for a review of an ultrasound contrast agent patent issued to Norwegian contrast developer Nycomed. MBI was granted a similar petition in July relating to
The U.S. Patent Office has granted a petition from Molecular Biosystems of San Diego asking for a review of an ultrasound contrast agent patent issued to Norwegian contrast developer Nycomed. MBI was granted a similar petition in July relating to ultrasound contrast patents received by Sonus Pharmaceutical (SCAN 8/6/97).
MBI said it filed the petition in response to Nycomed's assertion that MBI's Optison contrast agent infringes on one of its patents, U.S. patent no. 5,529,766. Nycomed filed patent infringement claims on Sept. 2 against MBI and Mallinckrodt, and in the same action sought to have its patents take priority over those of Sonus (SCAN 9/17/97).
MBI claims that it brought to the patent office's attention certain prior art references that were not included in Nycomed's patent application. MBI believes that the use of perfluorocarbon gases for ultrasound imaging is not patentable because of the prior art references.
MBI and its marketing partner Mallinckrodt also filed litigation in July in U.S. District Court for the District of Columbia, seeking to have the patents of Nycomed, Bracco, ImaRx Pharmaceutical and Du Pont Merck, and Sonus declared invalid.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
